Premium Financials Agenda

Faça Login ou Cadastre-se para ter acesso completo.

Supercharge your analysis with exclusive data on more than 6000 companies.

All your companies centralized on a single place.

A powerful Screener with all companies and indicators available on the site.

All the companies you've bookmarked to learn more.

Compare up to 5 companies, using more than 900 exclusive indicators between Stocks, REITs, Ações and FIIs.

Review and analyze updated financials of more than 6.000 Stocks, REITs, FIIs and Ações.

See the most complete corporate Events Calendar in the world.

Don't miss anything regarding the companies that matter most. Join our discussions.

All material facts published in the last 90 days.

Get ahead with the best companies ranked by the community.

CGON

CGON

Price • CG Oncology

CGON

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Historical stock price chart and annual return over the past years

CC

-35%

1 year

% Total

CGON